{"data":{"id":3328,"citation":"Escobar Z, Bjartell A, Canesin G, Evans-Axelsson S, Sterner O, Hellsten R, Johansson MH.: Preclinical Characterization of 3\u03b2-(N-Acetyl l-cysteine methyl ester)-2a\u03b2,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer. J Med Chem, Volume 59 (10), 2016","title":"Preclinical Characterization of 3\u03b2-(N-Acetyl l-cysteine methyl ester)-2a\u03b2,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer.","doi":"10.1021\/acs.jmedchem.5b01814","doi_url":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01814","pmid":"27111731","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/27111731\/","year":2016,"journal":"J Med Chem","volume":"59","issue":"10","page":"4551-4562","authors":[{"first_name":"Bjartell A","last_name":null,"full_name":null},{"first_name":"Canesin G","last_name":null,"full_name":null},{"first_name":"Escobar Z","last_name":null,"full_name":null},{"first_name":"Evans-Axelsson S","last_name":null,"full_name":null},{"first_name":"Hellsten R","last_name":null,"full_name":null},{"first_name":"Johansson MH.","last_name":null,"full_name":null},{"first_name":"Sterner O","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3328","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3328","created_at":"2024-05-21T20:11:43.000000Z","updated_at":null}}